Baird said last night's proposed 2014 Medicare Home Health reimbursement cuts is the worst possible outcome for the group. The analyst said the Health Care Facilities & Services sector has moved up in anticipation of a positive outcome and now expects Amedisys and peers to miss Q2 earnings and for Street estimates to move lower. Price target lowered to $9 from $10.